Endopeel offers a structured, non-surgical approach to soft-tissue repositioning based on chemical myoplasty / myopexy / myotension. For physicians seeking an effective alternative to invasive procedures—or looking to complement their current therapeutic arsenal—Endopeel provides a reproducible technique supported by more than 25 years of clinical use.

Unlike energy-based devices or volume-adding injectables, Endopeel acts directly on the muscular and aponeurotic architecture through a controlled chemo-myotensing effect. This allows physicians to achieve lifting, contouring, and definition without tissue trauma, volume distortion, or recovery time.

The method enables:

• Facial rejuvenation with an immediate lifting effect

• Three-dimensional body reshaping (gluteal projection, pectoral definition, abdominal contouring, etc.)

• Refinement of laxity without surgical excision

• Natural-looking outcomes that preserve expression and anatomical integrity

Because Endopeel is isovolumetric, treatments avoid the risks associated with overfilling, necrosis from vascular compromise, or the complications typical of thermal platforms. The technique is especially valuable for patients who are not candidates for surgery or who prefer minimally invasive solutions with no downtime.

Over the past decades, Endopeel has demonstrated a strong safety profile and consistent clinical results across multiple anatomical areas. Its adaptability enables integration into everyday aesthetic practice as a standalone procedure or as a synergistic complement to chemical peels.

Physicians adopting Endopeel benefit from:

• A standardized injection protocol

• A predictable mechanism of action

• Immediate functional feedback during the procedure

• High levels of patient satisfaction

As the field of aesthetic medicine evolves toward less invasive and more tissue-respectful treatments, Endopeel continues to expand its applications and scientific foundations.